Developer docs
API playgroundTry for free, no card

Search company profiles

Meihua Group

Full company profile

uuid003cfp2

Namestring
Meihua Group
Legal namestring
Meihua Holdings Group Co., Ltd.
Websiteurl
meihuagrp.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Meihua Group is a Chinese bio-manufacturer that produces amino acids and related ingredients through industrial fermentation for sale into global food, feed, and ingredient markets. The company operates ultra-large-scale fermentation facilities and is recognized as one of the top five global producers across multiple amino acid categories, including lysine, threonine, tryptophan, MSG, and nucleotides. Its product portfolio spans Livestock Nutrition, Umami Agents, Food Ingredients, Colloids, Plant-Based Protein, and Plant Nutrition, with newer categories such as DNA Synthesis under development. The company exports to 150 countries across five continents and is publicly listed on the Shanghai Stock Exchange under ticker 600873, with 10,000+ employees and primary operations in Hebei, China.

Meihua's business model is B2B ingredient supply at industrial scale, monetizing through volume sales of commodity and specialty fermentation-derived ingredients into food processors, animal feed formulators, and increasingly plant-based nutrition manufacturers. Customer segments are diversified across livestock feed (the dominant amino acid end market), food processing (umami agents, nucleotides), and emerging plant-based applications. Revenue is driven by production volume, global commodity pricing for amino acids, and feedstock (corn-based) cost dynamics. The company's growth strategy combines capacity expansion in core categories, geographic distribution breadth, and diversification into higher-growth adjacent verticals such as plant-based protein and plant nutrition, with portfolio reshaping evidenced by the 2026 divestiture of its Thailand facility to Novonesis.

Short descriptiontext

Meihua Group is a Chinese bio-manufacturer producing amino acids and ingredients via industrial fermentation for global food, feed, and plant-based nutrition markets, operating top-five global capacity across multiple amino acid categories and exporting to 150 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersHebei, China
HQ citystring
Hebei
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
amino acid manufacturing, fermentation technology, animal feed additives, bio-manufactured ingredients, umami flavor enhancers
Industry4 codes
1Amino Acid Premixes & Concentrates
CodeAFADAGAEPrimaryYes
2Bio-based Animal Feed Ingredients & Nutrition Co-products (e.g., DDGS, protein meals, yeast)
CodeEUAAAIAIPrimaryNo
3Soy Sauce, Tamari & Asian Condiments Manufacturing
CodeAFAKADAFPrimaryNo
4Plant Protein Ingredients Manufacturing (Isolates, Concentrates, Flours)
CodeAFAKAGAFPrimaryNo
NAICS code3 codes
  • Food Manufacturing311
  • Animal Food Manufacturing31111
  • Other Animal Food Manufacturing311119
SIC code3 codes
  • Food And Kindred Products2000
  • Miscellaneous Food Preparations & Kindred Products2090
  • Medicinal Chemicals & Botanical Products2833
Product category
Bio-manufactured Amino Acids and Ingredients
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Amino Acid Sales (Livestock Nutrition)
TypeOne Time License
Description

Manufacture and sale of amino acids including lysine, L-valine, L-glutamic acid for animal feed applications. Animal feed represents 57.9% of global amino acid volume consumption. Asia-Pacific holds 61.8% of global consumption.

meihua.group
2Umami and Flavor Enhancement Products
TypeOne Time License
Description

Production and sale of MSG (monosodium glutamate), inosinic acid, disodium nucleotides, and other flavor enhancers for food processing, restaurants, and home cooking applications.

meihua.group
3Pharmaceutical Intermediates and Healthcare Ingredients
TypeOne Time License
Description

Supply of pharmaceutical intermediates and functional food ingredients for healthcare applications.

meihua.group
4Bio-based Chemicals
TypeOne Time License
Description

Production of bio-based chemicals derived from fermentation processes using renewable plant-based resources.

meihua.group
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Meihua Group is a large-scale bio-manufacturing company that uses advanced fermentation technology to produce amino acids (lysine, L-valine, L-glutamic acid), umami agents (monosodium glutamate, nucleotides, I+G/inosinic and guanylic acid), and a related portfolio of ingredients for animal nutrition, human food, and pharmaceutical applications. The company operates ultra-large-scale bio-manufacturing facilities under a multi-product co-production model and exports its products to 150 countries. Its offerings span food ingredients, colloids, livestock health products, plant-based proteins, and plant nutrition products.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Global amino acid market projected to grow from US$25.6 billion (2025) to US$33.6 billion by 2032 at 4% CAGR
+4 more records
Product overview1 text field

Meihua Group is a bio-manufacturing company that provides eco-friendly nutritional solutions through advanced fermentation technology. The company's portfolio consists of seven main product categories (Livestock Nutrition, Umami Agents, Food Ingredients, Colloids and Polysaccharides, Livestock Health, Plant-Based Protein and Others, and Plant Nutrition) organized under a One-Stop Procurement Platform. These products span multiple technology focus areas including Amino Acids (core product line), Bio-based Chemicals, DNA Synthesis, Pharmaceutical Intermediates, Functional Food Ingredients, and Proteins/Peptides. The products serve diverse sectors including animal nutrition, human nutrition, flavor enhancement, and healthcare. Meihua operates large-scale bio-manufacturing facilities utilizing renewable plant-based resources to produce amino acids (L-Glutamic Acid, Lysine, L-Valine), nucleotides (Inosinic Acid, Disodium Nucleotide), and other fermentation-derived ingredients. The company exports to 150 countries and serves approximately 3 billion people globally.

Product and service10 records
1Lysine
CategoryAmino acids for animal nutrition
Description

Lysine is a fermentation-produced essential amino acid used as an additive in animal feed (poultry, swine, aquaculture) to improve protein quality and feed conversion efficiency. It is sold in bulk to industrial feed manufacturers.

2L-Valine
CategoryAmino acids for feed and pharma
Description

L-Valine is a branched-chain essential amino acid produced by fermentation and used in animal feed, pharmaceutical, and nutraceutical applications. It is sold to industrial feed manufacturers and pharmaceutical buyers.

3L-Glutamic Acid
CategoryAmino acids for food and pharma
Description

L-Glutamic Acid is a fermentation-produced amino acid used as a precursor for MSG and as an ingredient in pharmaceutical and food applications. Sold to industrial buyers.

4Monosodium Glutamate (MSG)
CategoryUmami flavor enhancers
Description

MSG is a fermentation-derived umami flavor enhancer used by food and seasoning manufacturers in soups, sauces, instant noodles, and savory snacks. Sold in bulk to industrial food processors.

5I+G (Disodium Inosinate/Disodium Guanylate) Nucleotides
CategoryUmami flavor enhancers
Description

I+G is a blend of disodium inosinate (IMP) and disodium guanylate (GMP) used as a flavor enhancer with strong synergy with MSG. Sold to food and seasoning manufacturers.

6Food Ingredients
CategoryFood ingredients
Description

Food ingredients is a broader category of fermentation-produced ingredients sold to food and beverage manufacturers for savory applications.

7Colloid products
CategoryFood and industrial ingredients
Description

Colloid products are ingredients used by food and industrial customers for texture and stability applications.

8Livestock Health products
CategoryAnimal health and nutrition
Description

Livestock health products are fermentation-derived ingredients for animal health and nutrition applications, sold to livestock producers and feed manufacturers.

9Plant-based Protein
CategoryPlant-based protein ingredients
Description

Plant-based protein is a fermentation-derived protein ingredient used in food and beverage applications as a plant-based protein source. Sold to food manufacturers.

10Plant Nutrition products
CategoryAgricultural inputs
Description

Plant nutrition products are fermentation-derived ingredients used in agricultural and crop nutrition applications. Sold to agricultural distributors and crop input companies.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierSignificantTypeStrategic or Co-development PartnerAnnounced on2026-04-08
Description

Novonesis signed an agreement to acquire a production facility in Rayong, Thailand from Meihua for approximately USD 50 million. This acquisition expands Novonesis' footprint in Southeast Asia and strengthens its fermentation capabilities, supporting the GROW strategy toward 2030. The facility is expected to be commercially operational in 2027 and will also support production of HMO (human milk oligosaccharides).

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Chinese fermentation company specializing in nucleotides and flavor enhancers, ranked among the top 5 global disodium nucleotide manufacturers. Direct competitor in Meihua's flavor enhancement product line.

TypeDirect peer
Description

South Korean conglomerate with a leading global fermentation and amino acid business (lysine, MSG, nucleotides). Direct competitor in animal feed amino acids and umami flavor enhancement, overlapping heavily with Meihua's core product portfolio.

TypeDirect peer
Description

Japanese global leader in amino acids, MSG, nucleotides and umami flavor enhancement. Competes directly with Meihua in inosinic acid and lysine, with stronger consumer brand recognition in human food applications.

TypeBroad incumbent
Description

Global agribusiness major with significant animal nutrition and fermentation ingredient capabilities. Competes with Meihua in lysine and feed-grade amino acids while also operating at much greater downstream scale across grain processing and food ingredients.

TypeEmerging player
Description

Global biotechnology leader in enzymes and microbial fermentation that recently acquired Meihua's Rayong facility (USD 50M, 2026). Operates in adjacent fermentation technology and HMO production, positioning it as both a strategic partner and partial future competitor in advanced fermentation-derived ingredients.

TypeDirect peer
Description

South Korean food and fermentation company and one of the top 5 global manufacturers in the disodium nucleotide market. Directly competes with Meihua in flavor-enhancing nucleotides for processed food applications.

TypeDirect peer
Description

German specialty chemicals company with a major animal nutrition amino acids business (lysine, methionine, threonine). Direct competitor in fermentation-derived feed-grade amino acids targeting global livestock customers.

TypeDirect peer
Description

Chinese state-affiliated biochemical producer with large-scale lysine and corn-based fermentation capacity. Direct competitor in the Chinese and global lysine markets, leveraging similar low-cost feedstock access as Meihua.

9Wuxi Jinghai Amino Acid
TypeDirect peer
Description

Chinese amino acid and inosinic acid manufacturer. Competes directly with Meihua in fermentation-derived flavor and feed amino acids, particularly within domestic Chinese markets.

10Shandong Shenglu Pharmaceutical
TypeDirect peer
Description

Chinese inosinic acid producer and competitor to Meihua in fermentation-derived flavor nucleotides. Operates in the same Chinese regulatory and feedstock environment, serving overlapping processed food customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Meihua Group

Bio-manufactured Amino Acids and Ingredientsmeihuagrp.com

Meihua Group is a Chinese bio-manufacturer producing amino acids and ingredients via industrial fermentation for global food, feed, and plant-based nutrition markets, operating top-five global capacity across multiple amino acid categories and exporting to 150 countries.

What Meihua Group does

Meihua Group is a Chinese bio-manufacturer that produces amino acids and related ingredients through industrial fermentation for sale into global food, feed, and ingredient markets. The company operates ultra-large-scale fermentation facilities and is recognized as one of the top five global producers across multiple amino acid categories, including lysine, threonine, tryptophan, MSG, and nucleotides. Its product portfolio spans Livestock Nutrition, Umami Agents, Food Ingredients, Colloids, Plant-Based Protein, and Plant Nutrition, with newer categories such as DNA Synthesis under development. The company exports to 150 countries across five continents and is publicly listed on the Shanghai Stock Exchange under ticker 600873, with 10,000+ employees and primary operations in Hebei, China.

Meihua's business model is B2B ingredient supply at industrial scale, monetizing through volume sales of commodity and specialty fermentation-derived ingredients into food processors, animal feed formulators, and increasingly plant-based nutrition manufacturers. Customer segments are diversified across livestock feed (the dominant amino acid end market), food processing (umami agents, nucleotides), and emerging plant-based applications. Revenue is driven by production volume, global commodity pricing for amino acids, and feedstock (corn-based) cost dynamics. The company's growth strategy combines capacity expansion in core categories, geographic distribution breadth, and diversification into higher-growth adjacent verticals such as plant-based protein and plant nutrition, with portfolio reshaping evidenced by the 2026 divestiture of its Thailand facility to Novonesis.

Meihua Group firmographics

Firmographics
Name
Meihua Group
Legal name
Meihua Holdings Group Co., Ltd.
Website
https://meihuagrp.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Meihua Group is a Chinese bio-manufacturer producing amino acids and ingredients via industrial fermentation for global food, feed, and plant-based nutrition markets, operating top-five global capacity across multiple amino acid categories and exporting to 150 countries.
Ownership category
akta.pro rank

Meihua Group industry classification

Industry
Product category
Bio-manufactured Amino Acids and Ingredients
NAICS
Food Manufacturing (311), Animal Food Manufacturing (31111), Other Animal Food Manufacturing (311119)
SIC
Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090), Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Amino Acid Premixes & Concentrates (AFADAGAE)
akta.pro secondary industries
Bio-based Animal Feed Ingredients & Nutrition Co-products (e.g., DDGS, protein meals, yeast) (EUAAAIAI), Soy Sauce, Tamari & Asian Condiments Manufacturing (AFAKADAF), Plant Protein Ingredients Manufacturing (Isolates, Concentrates, Flours) (AFAKAGAF)

Keywords

  • Amino acid manufacturing
  • Fermentation technology
  • Animal feed additives
  • Bio-manufactured ingredients
  • Umami flavor enhancers

Where Meihua Group is headquartered

Location

Headquarters

HQ city
Hebei
HQ country
China
HQ region
Asia

Offices1 record

Markets served

Meihua Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Amino Acid Sales (Livestock Nutrition): Manufacture and sale of amino acids including lysine, L-valine, L-glutamic acid for animal feed applications. Animal feed represents 57.9% of global amino acid volume consumption. Asia-Pacific holds 61.8% of global consumption.
  2. Umami and Flavor Enhancement Products: Production and sale of MSG (monosodium glutamate), inosinic acid, disodium nucleotides, and other flavor enhancers for food processing, restaurants, and home cooking applications.
  3. Pharmaceutical Intermediates and Healthcare Ingredients: Supply of pharmaceutical intermediates and functional food ingredients for healthcare applications.
  4. Bio-based Chemicals: Production of bio-based chemicals derived from fermentation processes using renewable plant-based resources.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Meihua Group product offering

Product offering

Core offering

Meihua Group is a large-scale bio-manufacturing company that uses advanced fermentation technology to produce amino acids (lysine, L-valine, L-glutamic acid), umami agents (monosodium glutamate, nucleotides, I+G/inosinic and guanylic acid), and a related portfolio of ingredients for animal nutrition, human food, and pharmaceutical applications. The company operates ultra-large-scale bio-manufacturing facilities under a multi-product co-production model and exports its products to 150 countries. Its offerings span food ingredients, colloids, livestock health products, plant-based proteins, and plant nutrition products.

Product overview

Meihua Group is a bio-manufacturing company that provides eco-friendly nutritional solutions through advanced fermentation technology. The company's portfolio consists of seven main product categories (Livestock Nutrition, Umami Agents, Food Ingredients, Colloids and Polysaccharides, Livestock Health, Plant-Based Protein and Others, and Plant Nutrition) organized under a One-Stop Procurement Platform. These products span multiple technology focus areas including Amino Acids (core product line), Bio-based Chemicals, DNA Synthesis, Pharmaceutical Intermediates, Functional Food Ingredients, and Proteins/Peptides. The products serve diverse sectors including animal nutrition, human nutrition, flavor enhancement, and healthcare. Meihua operates large-scale bio-manufacturing facilities utilizing renewable plant-based resources to produce amino acids (L-Glutamic Acid, Lysine, L-Valine), nucleotides (Inosinic Acid, Disodium Nucleotide), and other fermentation-derived ingredients. The company exports to 150 countries and serves approximately 3 billion people globally.

Differentiator

Problem solved

Functional benefit

Products and services

  • Lysine Lysine is a fermentation-produced essential amino acid used as an additive in animal feed (poultry, swine, aquaculture) to improve protein quality and feed conversion efficiency. It is sold in bulk to industrial feed manufacturers.
  • L-Valine L-Valine is a branched-chain essential amino acid produced by fermentation and used in animal feed, pharmaceutical, and nutraceutical applications. It is sold to industrial feed manufacturers and pharmaceutical buyers.
  • L-Glutamic Acid L-Glutamic Acid is a fermentation-produced amino acid used as a precursor for MSG and as an ingredient in pharmaceutical and food applications. Sold to industrial buyers.
  • Monosodium Glutamate (MSG) MSG is a fermentation-derived umami flavor enhancer used by food and seasoning manufacturers in soups, sauces, instant noodles, and savory snacks. Sold in bulk to industrial food processors.
  • I+G (Disodium Inosinate/Disodium Guanylate) Nucleotides I+G is a blend of disodium inosinate (IMP) and disodium guanylate (GMP) used as a flavor enhancer with strong synergy with MSG. Sold to food and seasoning manufacturers.
  • Food Ingredients Food ingredients is a broader category of fermentation-produced ingredients sold to food and beverage manufacturers for savory applications.
  • Colloid products Colloid products are ingredients used by food and industrial customers for texture and stability applications.
  • Livestock Health products Livestock health products are fermentation-derived ingredients for animal health and nutrition applications, sold to livestock producers and feed manufacturers.
  • Plant-based Protein Plant-based protein is a fermentation-derived protein ingredient used in food and beverage applications as a plant-based protein source. Sold to food manufacturers.
  • Plant Nutrition products Plant nutrition products are fermentation-derived ingredients used in agricultural and crop nutrition applications. Sold to agricultural distributors and crop input companies.

Quantifiable outcome

  • Global amino acid market projected to grow from US$25.6 billion (2025) to US$33.6 billion by 2032 at 4% CAGR
  • +4 more outcomes

Companies that use Meihua Group

Customer profile

Segments4 records

Ideal customer profiles3 records

Meihua Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Meihua Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Novonesis (Novozymes A/S)significantStrategic or Co-development Partner · 8 April 2026Novonesis signed an agreement to acquire a production facility in Rayong, Thailand from Meihua for approximately USD 50 million. This acquisition expands Novonesis' footprint in Southeast Asia and strengthens its fermentation capabilities, supporting the GROW strategy toward 2030. The facility is expected to be commercially operational in 2027 and will also support production of HMO (human milk oligosaccharides).

Scale indicators9 records

Recent moves6 records

Expansion highlights8 records

Meihua Group competitors and assessment

Company assessment

Direct peers

  • Star Lake Bioscience: Chinese fermentation company specializing in nucleotides and flavor enhancers, ranked among the top 5 global disodium nucleotide manufacturers. Direct competitor in Meihua's flavor enhancement product line.
  • CJ CheilJedang: South Korean conglomerate with a leading global fermentation and amino acid business (lysine, MSG, nucleotides). Direct competitor in animal feed amino acids and umami flavor enhancement, overlapping heavily with Meihua's core product portfolio.
  • Ajinomoto: Japanese global leader in amino acids, MSG, nucleotides and umami flavor enhancement. Competes directly with Meihua in inosinic acid and lysine, with stronger consumer brand recognition in human food applications.
  • Daesang Corporation: South Korean food and fermentation company and one of the top 5 global manufacturers in the disodium nucleotide market. Directly competes with Meihua in flavor-enhancing nucleotides for processed food applications.
  • Evonik Industries: German specialty chemicals company with a major animal nutrition amino acids business (lysine, methionine, threonine). Direct competitor in fermentation-derived feed-grade amino acids targeting global livestock customers.
  • COFCO Biochemical: Chinese state-affiliated biochemical producer with large-scale lysine and corn-based fermentation capacity. Direct competitor in the Chinese and global lysine markets, leveraging similar low-cost feedstock access as Meihua.
  • Wuxi Jinghai Amino Acid: Chinese amino acid and inosinic acid manufacturer. Competes directly with Meihua in fermentation-derived flavor and feed amino acids, particularly within domestic Chinese markets.
  • Shandong Shenglu Pharmaceutical: Chinese inosinic acid producer and competitor to Meihua in fermentation-derived flavor nucleotides. Operates in the same Chinese regulatory and feedstock environment, serving overlapping processed food customers.

Broad incumbents

  • ADM (Archer Daniels Midland): Global agribusiness major with significant animal nutrition and fermentation ingredient capabilities. Competes with Meihua in lysine and feed-grade amino acids while also operating at much greater downstream scale across grain processing and food ingredients.

Emerging players

  • Novonesis (Novozymes): Global biotechnology leader in enzymes and microbial fermentation that recently acquired Meihua's Rayong facility (USD 50M, 2026). Operates in adjacent fermentation technology and HMO production, positioning it as both a strategic partner and partial future competitor in advanced fermentation-derived ingredients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Meihua Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Meihua Group leadership team

Management profile

Number of profiles

Meihua Group subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Meihua Group funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Meihua Group M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Meihua Group

What does Meihua Group do?

Meihua Group is a large-scale bio-manufacturing company that uses advanced fermentation technology to produce amino acids (lysine, L-valine, L-glutamic acid), umami agents (monosodium glutamate, nucleotides, I+G/inosinic and guanylic acid), and a related portfolio of ingredients for animal nutrition, human food, and pharmaceutical applications. The company operates ultra-large-scale bio-manufacturing facilities under a multi-product co-production model and exports its products to 150 countries. Its offerings span food ingredients, colloids, livestock health products, plant-based proteins, and plant nutrition products.

Is Meihua Group a public or private company?

Meihua Group is a private company. It is classified as public and is currently operating.

When was Meihua Group founded?

Meihua Group was founded in 2005. It employs 5,001 to 10,000 people.

Where is Meihua Group based?

Meihua Group is headquartered in Hebei, China, in the Asia region.

How does Meihua Group make money?

Four revenue lines are on record. Amino Acid Sales (Livestock Nutrition) is the primary driver. The others are umami and Flavor Enhancement Products, pharmaceutical Intermediates and Healthcare Ingredients and bio-based Chemicals.

Who are Meihua Group's main competitors?

Direct peers on record are Star Lake Bioscience, CJ CheilJedang, Ajinomoto, Daesang Corporation, Evonik Industries, COFCO Biochemical, Wuxi Jinghai Amino Acid and Shandong Shenglu Pharmaceutical. ADM (Archer Daniels Midland) is listed as a broad incumbent. Novonesis (Novozymes) is listed as an emerging player.

Does Meihua Group have an API?

No public API is recorded for Meihua Group.

What industry is Meihua Group in?

Meihua Group's product category is Bio-manufactured Amino Acids and Ingredients. Its primary akta.pro industry code is AFADAGAE, Amino Acid Premixes & Concentrates, with a secondary code of EUAAAIAI, Bio-based Animal Feed Ingredients & Nutrition Co-products (e.g., DDGS, protein meals, yeast). Its NAICS code is 311 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrtimesInosinic Acid Market Driven by Increasing Use of Functional Food Ingredients – PR TimesThe global Inosinic Acid Market was valued at USD 3.91 billion in 2025 and is projected to reach USD 5.11 billion by 2032, growing at a compound annual growth rate of 3.9% during the forecast period, according to Stellar Market Research. Market growth is driven by increasing demand for umami flavors, rising consumption of processed and convenience foods, and growing preference for enhanced flavor experiences among consumers worldwide. Key players in the market include Ajinomoto Co., Inc., Meihua Holdings Group Co., Ltd., Shandong Shenglu Pharmaceutical Co., Ltd., and Wuxi Jinghai Amino Acid Co., Ltd., with Asia Pacific expected to witness the strongest regional growth.PR NewswireLysine Market Expands as Precision Animal Nutrition Gains Global Momentum | CAGR 6.4%The global lysine market is projected to grow from US$6.3 billion in 2026 to US$9.7 billion by 2033, registering a CAGR of 6.4%, driven by rising demand for animal protein and high-efficiency feed formulations in poultry, swine, and aquaculture production systems. Asia Pacific holds the largest market share at approximately 40.6% and is expected to remain the fastest-growing region, with China dominating regional production due to its extensive fermentation infrastructure. Major producers including Meihua Holdings Group, CJ CheilJedang, COFCO Biochemical, Evonik Industries, and Archer Daniels Midland are expanding fermentation capacity to strengthen global supply capabilities.openPR.comGlobal Disodium Nucleotide Market 2026: Emerging Growth Pathways, Leading Players & Industry Forecast InsightsQY Research published a market report assessing the global Disodium Nucleotide market, which was valued at US$ 618.46 million in 2025 and is forecast to reach US$ 778.84 million by 2032, growing at a CAGR of 3.62%. The top five global manufacturers—CJ Group, Ajinomoto, Meihua Holdings Group, Star Lake Bioscience, and Daesang Corporation—collectively accounted for approximately 91.09% of global market revenue in 2025.Fact.MRPullulan Market Size and Share Forecast Outlook 2025 to 2035The global pullulan market is projected to grow from USD 714.5 million in 2025 to USD 1,163.8 million by 2035, registering a compound annual growth rate of 5.0%. This expansion is driven by increasing demand for sustainable packaging, pharmaceutical applications like oral films, and functional food ingredients. Key growth regions include the United States, China, and Japan, with major industry players such as Hayashibara, Meihua Group, and Nagase leading the competitive landscape.https://www.avcj.comAdvent acquires China's largest medical capsule makerAdvent International has acquired a majority stake in Guangsheng Medicinal Capsule (GS Capsule), China's largest medical capsule maker, from Meihua Holdings Group and co-investors. GS Capsule produces various capsule types for pharmaceutical companies globally, marking Advent's continued expansion in the Asian healthcare sector following recent acquisitions in India.PR NewswireGlobal Monosodium Glutamate (MSG) Market 2019-2024 Key Players, Growth, Price, Demands and Forecasts - ReportsnReportsA market research report by ReportsnReports provides an overview of the global Monosodium Glutamate (MSG) market from 2019 to 2024, noting that Asian production accounts for more than 90% of world MSG output due to abundant feedstocks and labor. The report identifies key manufacturers including Ajinomoto Group Company, McCormick & Company, Fufeng Group Company, and Meihua Biological Technology among others. The analysis indicates the industry is approaching maturity with slow price declines expected as competition intensifies and international players expand through factory construction and investments.PR NewswireGlobal Monosodium Glutamate (MSG) Market 2017-2021: Key Vendors are AJINOMOTO, COFCO, FUFENG, Lotus Health Industry & Meihua - Research and MarketsResearch and Markets announced the addition of a new report detailing the global Monosodium Glutamate (MSG) market forecast from 2017 to 2021. The report projects a compound annual growth rate of 4.80%, driven by rising meat consumption and demand for flavor enhancers in food processing, while noting challenges related to consumer health concerns about artificial ingredients.